About KyDo Therapeutics
KyDo Therapeutics GmbH (KyDo) is a preclinical-stage biotechnology company committed to developing novel covalent- allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs. KyDo was jointly founded by Lead Discovery Center GmbH (LDC) together with scientists from the Rauh Lab at TU Dortmund University.
Advertisement
